Recent advances in technology have enabled 3D printing of biocompatible parts, driving major innovations in the medical industry. At the same time, 3D bioprinting has raised a number of legal questions, including patent eligibility under Section 101. In this podcast, Finnegan attorneys Barbara R. Rudolph and Kai Rajan provide insight into intellectual property considerations for 3D bioprinting.